Catabasis Pharmaceuticals, Inc.

Catabasis Pharmaceuticals, Inc.

Catabasis Pharmaceuticals, Inc.

Overview
Date Founded

2008

Headquarters

100 High Street,28th floor,Boston, MA 02110

Type of Company

Public

Employees (Worldwide)

27

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.

Contact Data
Trying to get in touch with decision makers at Catabasis Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chief Commercial Officer

Chief Scientific Officer

Chief Medical Officer & Senior Vice President-Clinical Development

Treasurer & Vice President-Finance

Vice President, Regulatory Affairs

Vice President, Corporate Affairs

Senior Vice President & General Counsel

Director of Pharmacology

Director

Board of Directors

Former President & Chief Executive Officer at NitroMed, Inc.

Co-Founder at Cerium Pharmaceuticals, Inc.

Co-Founder at Verve Therapeutics, Inc.

Chief Operating Officer at Boston Pharmaceuticals

Co-Founder at Catabasis Pharmaceuticals, Inc.

Chief Business Officer & Head of Corporate Development at Jounce Therapeutics, Inc.

Former President & Chief Executive Officer at Achillion Pharmaceuticals Inc.

Managing Partner at SV Health Investors LLP

Paths to Catabasis Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Catabasis Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Altium Capital Management LP is an American private company located in New York, NY, with subsidiaries in the United States. The firm provides investment advice.

Details Hidden

Corriente Advisors invests in the public equity and alternative investment markets in the US. The firm employs a combination of in-house and external research to construct its portfolios.

Details Hidden

Worth Venture Partners LLC is a private company headquartered in New York, NY, with a presence in the United States, that provides investment advice. It was founded in 2012. David Alexander Wertentheil and Abby I. Flamholz are the current co-CEOs of the firm.

Recent Transactions
Details Hidden

Catabasis Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Catabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Details Hidden

Catabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Transaction Advisors
Escrow Agent

Advised onCatabasis Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onCatabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Underwriter

Advised onCatabasis Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onCatabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Managing Director

Advised onCatabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Counsel

Advised onCatabasis Pharmaceuticals, Inc. issued USD Units Consisting of Common Stock and Warrants

Advisors & Consultants
Legal Advisor

Chair, Transactional Department at Wilmer Cutler Pickering Hale and Dorr LLP

Advisor

Chief Financial Officer at Boston Pharmaceuticals

Key Stats and Financials As of 2019
Market Capitalization
$126M
Total Enterprise Value
$32.2M
Earnings Per Share
$-2.35
Revenue
$0
Debt TEV
0.07x
TEVNet Income
-1.22x
Net Profit
$-26.3M
Total Equity
$35.7M
Total Debt
$2.25M
EBITDA
$-27.1M
Non-Profit Donations & Grants
Investors
Details Hidden

Founded in 1993, SV Health Investors LLC is a venture capital firm headquartered in Boston. The firm is a subsidiary of SV Life Sciences Advisers LLP, a venture capital investment firm based in London. SV Health Investors was formerly known as Schroder Ventures Life Sciences. They advise and manage several venture capital funds for corporate clients and private individuals.

Details Hidden

Clarus Ventures focuses on investments in the life science industry. The firm's invests primarily in biopharmaceutical and medical technology companies. Clarus Ventures has particular expertise in research and development, commercialization, business development and operations management at the global level. The firm also makes investment in public company.

Details Hidden

MedImmune Ventures invests in both public and private biotechnology companies located across the globe primarily in North America. The firm targets companies operating in the fields of molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging and healthcare IT. The firm provides financing for seed, early, later and mezzanine stage capital requirements with an investment size ranging from $5 to $10 million per round.

Competitors
Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Sarepta Therapeutics, Inc. Pharmaceuticals - Cambridge, Massachusetts

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

FibroGen, Inc. Biotechnology - San Francisco, CA

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Catabasis Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Catabasis Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Catabasis Pharmaceuticals, Inc..